Affordable Access

deepdyve-link
Publisher Website

Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.

Authors
  • Arima, R1
  • Hautakoski, A2
  • Marttila, M3
  • Arffman, M4
  • Sund, R5
  • Ilanne-Parikka, P6
  • Kangaskokko, J7
  • Hinkula, M8
  • Puistola, U9
  • Läärä, E10
  • 1 Department of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center Oulu, University of Oulu and University Hospital of Oulu, P.O. Box 23, FIN-90029 Oulu, Finland. Electronic address: [email protected] , (Finland)
  • 2 Children, Adolescents and Families Unit, Department of Welfare, National Institute for Health and Welfare, P.O. Box 310, FIN-90101 Oulu, Finland. Electronic address: [email protected] , (Finland)
  • 3 Children, Adolescents and Families Unit, Department of Welfare, National Institute for Health and Welfare, P.O. Box 310, FIN-90101 Oulu, Finland. Electronic address: [email protected] , (Finland)
  • 4 Service System Research Unit, National Institute for Health and Welfare, P.O. Box 30, FIN-00271 Helsinki, Finland. Electronic address: [email protected] , (Finland)
  • 5 Centre for Research Methods, Department of Social Research, University of Helsinki, Helsinki, Finland; Institute of Clinical Medicine, University of Eastern Finland. P.O. Box 1627, FIN-70211 Kuopio, Finland. Electronic address: [email protected] , (Finland)
  • 6 Science Center, Tampere University Hospital, Tampere, Finland; The Diabetes Center, Finnish Diabetes Association, FIN-33680 Tampere, Finland. Electronic address: [email protected] , (Finland)
  • 7 Department of Pathology, Medical Research Center Oulu, University of Oulu and University Hospital of Oulu, P.O. Box 50, FIN-90029 Oulu, Finland. Electronic address: [email protected] , (Finland)
  • 8 Department of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center Oulu, University of Oulu and University Hospital of Oulu, P.O. Box 23, FIN-90029 Oulu, Finland. Electronic address: [email protected] , (Finland)
  • 9 Department of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center Oulu, University of Oulu and University Hospital of Oulu, P.O. Box 23, FIN-90029 Oulu, Finland. Electronic address: [email protected] , (Finland)
  • 10 Research Unit of Mathematical Sciences, University of Oulu, P.O. Box 8000, FIN-90014 Oulu, Finland. Electronic address: [email protected] , (Finland)
Type
Published Article
Journal
Gynecologic Oncology
Publisher
Elsevier
Publication Date
Dec 01, 2017
Volume
147
Issue
3
Pages
678–683
Identifiers
DOI: 10.1016/j.ygyno.2017.10.014
PMID: 29054569
Source
Medline
Keywords
License
Unknown

Abstract

Our findings are inconclusive as to the possible effect of metformin on the prognosis of endometrioid EC in women with T2D. However, use of metformin may reduce mortality from other causes.

Report this publication

Statistics

Seen <100 times